Table 2. Peptides representative for major presentable regions of Spike.
15aa peptides from the center of peaks having at least 5 consecutive peptides with MEDi-MA scores above the 85th percentile are shown. Sequences overlapping at least 9aa with the minimum sequences of presented peptide clusters identified by Knierman et al. (25) are marked by an asterisk. Peptides overlapping at least 9aa with T cell reactive peptides identified by Peng et al. (13) and Nelde et al. (14) are highlighted in bold.
Position | DRB10701 | Position | DRB10404 | Position | DRB11501 | Position | DPA10202B10501 |
8 | LPLVSSQCVNLTTRT | 7 | LLPLVSSQCVNLTTR | 59 | FSNVTWFHAIHVSGT | 40 | DKVFRSSVLHSTQDL* |
27 | AYTNSFTRGVYYPDK* | 62 | VTWFHAIHVSGTNGT | 237 | RFQTLLALHRSYLTP* | 50 | STQDLFLPFFSNVTW* |
42 | VFRSSVLHSTQDLFL* | 232 | GINITRFQTLLALHR* | 302 | TLKSFTVEKGIYQTS* | 70 | VSGTNGTKRFDNPVL |
60 | SNVTWFHAIHVSGTN | 402 | IRGDEVRQIAPGQTG* | 309 | EKGIYQTSNFRVQPT* | 75 | GTKRFDNPVLPFNDG |
111 | DSKTQSLLIVNNATN | 513 | LSFELLHAPATVCGP* | 402 | IRGDEVRQIAPGQTG* | 80 | DNPVLPFNDGVYFAS |
202 | KIYSKHTPINLVRDL* | 678 | TNSPRRARSVASQSI | 433 | VIAWNSNNLDSKVGG* | 106 | FGTTLDSKTQSLLIV |
230 | PIGINITRFQTLLAL | 683 | RARSVASQSIIAYTM | 470 | TEIYQAGSTPCNGVE* | 111 | DSKTQSLLIVNNATN |
239 | QTLLALHRSYLTPGD* | 688 | ASQSIIAYTMSLGAE* | 631 | PTWRVYSTGSNVFQT* | 201 | FKIYSKHTPINLVRD* |
309 | EKGIYQTSNFRVQPT* | 854 | KFNGLTVLPPLLTDE* | 677 | QTNSPRRARSVASQS* | 230 | PIGINITRFQTLLAL |
314 | QTSNFRVQPTESIVR* | 866 | TDEMIAQYTSALLAG* | 682 | RRARSVASQSIIAYT | 235 | ITRFQTLLALHRSYL* |
490 | FPLQSYGFQPTNGVG* | 919 | NQKLIANQFNSAIGK* | 687 | VASQSIIAYTMSLGA* | 495 | YGFQPTNGVGYQPYR |
639 | GSNVFQTRAGCLIGA* | 931 | IGKIQDSLSSTASAL* | 692 | IIAYTMSLGAENSVA | 551 | VLTESNKKFLPFQQF* |
679 | NSPRRARSVASQSII* | 936 | DSLSSTASALGKLQD* | 752 | LLLQYGSFCTQLNRA | 556 | NKKFLPFQQFGRDIA* |
684 | ARSVASQSIIAYTMS | 952 | VNQNAQALNTLVKQL* | 784 | QVKQIYKTPPIKDFG | 680 | SPRRARSVASQSIIA* |
689 | SQSIIAYTMSLGAEN* | 957 | QALNTLVKQLSSNFG | 856 | NGLTVLPPLLTDEMI | 704 | SVAYSNNSIAIPTNF |
694 | AYTMSLGAENSVAYS | 962 | LVKQLSSNFGAISSV* | 866 | TDEMIAQYTSALLAG* | 782 | FAQVKQIYKTPPIKD* |
714 | IPTNFTISVTTEILP | 982 | SRLDKVEAEVQIDRL* | 899 | AMQMAYRFNGIGVTQ* | 812 | PSKRSFIEDLLFNKV* |
782 | FAQVKQIYKTPPIKD | 1016 | AEIRASANLAATKMS* | 913 | QNVLYENQKLIANQF | 871 | AQYTSALLAGTITSG* |
869 | MIAQYTSALLAGTIT* | 1063 | LHVTYVPAQEKNFTT | 918 | ENQKLIANQFNSAIG* | 918 | ENQKLIANQFNSAIG* |
880 | GTITSGWTFGAGAAL | 1170 | SGINASVVNIQKEID* | 961 | TLVKQLSSNFGAISS* | 928 | NSAIGKIQDSLSSTA* |
885 | GWTFGAGAALQIPFA | 997 | ITGRLQSLQTYVTQQ | 960 | NTLVKQLSSNFGAIS* | ||
896 | IPFAMQMAYRFNGIG* | 1002 | QSLQTYVTQQLIRAA | 1014 | RAAEIRASANLAATK* | ||
1008 | VTQQLIRAAEIRASA* | 1007 | YVTQQLIRAAEIRAS* | 1019 | RASANLAATKMSECV | ||
1013 | IRAAEIRASANLAAT* | 1012 | LIRAAEIRASANLAA* | 1040 | VDFCGKGYHLMSFPQ | ||
1070 | AQEKNFTTAPAICHD | 1017 | EIRASANLAATKMSE* | 1045 | KGYHLMSFPQSAPHG | ||
1066 | TYVPAQEKNFTTAPA | ||||||
1071 | QEKNFTTAPAICHDG | ||||||
1088 | HFPREGVFVSNGTHW | ||||||
1134 | NNTVYDPLQPELDSF* |